**FDA Recalls Thousands Of Cymbalta Bottles Over Chemical**

muazhan

You need 2 min read

·

Post on Oct 24, 2024

60 visitor like this post

Share

FDA Recalls Thousands of Cymbalta Bottles Over Chemical Contamination

The Food and Drug Administration (FDA) has issued a nationwide recall of thousands of bottles of Cymbalta (duloxetine hydrochloride) capsules due to potential contamination with N-nitroso-duloxetine. This chemical, classified as a probable human carcinogen, was found in some batches of the antidepressant medication.

What is N-nitroso-duloxetine?

N-nitroso-duloxetine is a potential human carcinogen, meaning it could increase the risk of developing cancer. This chemical is formed during the manufacturing process and is not normally present in Cymbalta.

Why the Recall?

The recall was initiated after tests revealed the presence of N-nitroso-duloxetine above the acceptable limit in certain batches of Cymbalta capsules. The FDA considers this level of contamination to pose a potential health risk.

Which Batches Are Affected?

The recall affects specific lots of Cymbalta capsules manufactured by Eli Lilly and Company. To determine if your medication is part of the recall, check the lot number printed on the bottle. The FDA has published a complete list of affected lots on their website.

What Should Consumers Do?

If you have any bottles of Cymbalta that match the recalled lot numbers, stop taking the medication immediately. Contact your pharmacist or healthcare provider for guidance on obtaining a replacement prescription.

How to Dispose of Recalled Medication:

The FDA recommends following your local guidelines for safely disposing of prescription drugs. Many pharmacies offer drug take-back programs, while others recommend flushing the medication down the toilet.

Important Considerations:

• Do not flush the medication unless advised by the FDA or your local waste management agency.
• Always consult with your healthcare provider before stopping any prescribed medication.
• Never take medication that has been recalled or that you suspect might be contaminated.

Stay Informed:

The FDA continues to investigate the source of the contamination and will provide updates as they become available. Monitor the FDA website and official channels for further information and guidance.

Key takeaways:

• The FDA has recalled specific lots of Cymbalta capsules due to N-nitroso-duloxetine contamination.
• N-nitroso-duloxetine is a potential human carcinogen.
• Consumers should stop taking affected medication and contact their healthcare provider.
• Dispose of recalled medication safely according to local guidelines.

This article is intended for informational purposes only and should not be considered medical advice. Always consult with your healthcare provider for personalized guidance.